Improvement of Solubility and Dissolution of Niclosamide using Metal Organic Framework 5 (MOF-5)
DOI:
https://doi.org/10.31351/vol34iss3pp162-172Keywords:
Dissolution, improvement, MOF-5, niclosamide, solubilityAbstract
Metal-organic frameworks-5 (MOF-5) were explored for enhancement of the solubility and dissolution of the drug niclosamide (NIC). MOF-5 was synthesized by solvothermal method and NIC was loaded into it (NIC@MOF-5). Characterization was done using field-emission scanning electron microscopy (FE-SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Brunauer-Emmett-Teller surface area (BET-SA), and energy-dispersive X-ray spectroscopy (EDS). The effect of loading time on the percentages of entrapment efficiency (%EE) and loading capacity (%LC) were studied. The effect of incorporation into MOF-5 on saturated solubility and dissolution profiles of NIC was investigated in three different media: acidic buffer solution (ABS) pH 1.2, deionized water (DW) pH 6.2, and phosphate buffer solution (PBS) pH 7.4. The results showed that the solubility of NIC was significantly improved upon incorporation into MOF-5 in all media. In ABS pH 1.2, it was improved by 3.4 times (10.63 ± 1.04 µg/ml versus 3.17 ± 0.55 µg/ml). In DW pH 6.2, it was improved by 4.7 times (60.37 ± 4.74 µg/ml versus 12.83 ± 1.76 µg/ml). The biggest improvement was in PBS pH 7.4 by 6.1 times (209.85 ± 9.77 µg/ml versus 34.5 ± 1.66 µg/ml. For dissolution, the cumulative release at the end of point was significantly higher for NIC@MOF-5 in all three media: 51.20% ± 6.52% versus 10.77% ± 1.78% in ABS pH 1.2, 54.09% ± 1.81% versus 12.44% ± 0.57% in DW pH 6.2, and 84.87% ± 9.99% versus 19.48% ± 1.82% in PBS pH 7.4. Characterization confirmed the identity of NIC and MOF-5 as well as loading of NIC into MOF-5 without significant interactions. It is, therefore, concluded that MOF-5 is a feasible formulation approach to improve the solubility of and dissolution of NIC in either acidic media, water, or basic media.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Han J, Xiao B, Le PK, Mangwandi C. Enhancement of the solubility of BS class II drugs with MOF and MOF/GO composite materials: Case studies of felodipine, ketoprofen and ibuprofen. Materials. 2023;16(4):1554-68.
Jaafar IS, Radhi AA. Co-amorphous system: A promising strategy for delivering poorly water-soluble drugs. Iraqi journal of pharmaceutical sciences. 2020;29(1):1-11.
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. European journal of pharmaceutics and biopharmaceutics. 2000;50(1):47-60.
Maranescu B, Visa A. Applications of metal-organic frameworks as drug delivery systems. International journal of molecular sciences. 2022;23(8):4458-76.
Suresh K, Matzger AJ. Enhanced drug delivery by dissolution of amorphous drug encapsulated in a water unstable metal-organic framework (MOF). Angewandte chemie. 2019;58(47):16790-4.
Ohsaki S, Satsuma H, Nakamura H, Watano S. Improvement of solubility of sparingly water-soluble drug triggered by metal-organic framework. Journal of drug delivery dcience and technology. 2021;63:102490.
Bajaj T, Singh C, Gupta GD. Novel metal organic frameworks improves solubility and oral absorption of mebendazole: Physicochemical characterization and in vitro-in vivo evaluation. Journal of drug delivery dcience and technology. 2022;70:103264.
He Y, Zhang W, Guo T, Zhang G, Qin W, Zhang L, et al. Drug nanoclusters formed in confined nano-cages of CD-MOF: Dramatic enhancement of solubility and bioavailability of azilsartan. Acta pharmaceutica sinica B. 2019;9(1):97-106.
Bayer A. Yomesan (Niclosamide) PIL: Bayer AG; 2022 [Available from: https://www.bayer.com/sites/default/files/YOMESAN_EN_PI.pdf.
Needham D. The pH dependence of niclosamide solubility, dissolution, and morphology: Motivation for potentially universal mucin-penetrating nasal and throat Sprays for COVID19, its variants and other viral infections. Pharmaceutical research. 2022;39(1):115-41.
Kapale SS, Chaudhari HK. Niclosamide and challenges in chemical modifications: A broad review on enhancement of solubility. Journal of the indian chemical society. 2021;98(12):100262.
Chen W, Mook RAJ, Premont RT, Wang J. Niclosamide: Beyond an antihelminthic drug. Cellular signalling. 2018;41:89-96.
Jara MO, Warnken ZN, Williams RO. Amorphous solid dispersions and the contribution of nanoparticles to in vitro dissolution and in vivo testing: Niclosamide as a case study. Pharmaceutics. 2021;13(1):97-111.
Schweizer MT, Haugk K, McKiernan JS, Gulati R, Cheng HH, Maes JL, et al. A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer. PloS one. 2018;13(6):e0198389.
Grifasi F, Chierotti MR, Gaglioti K, Gobetto R, Maini L, Braga D, et al. Using salt cocrystals to improve the solubility of niclosamide. Crystal growth & design. 2015;15(4):1939-48.
Rehman MU, Khan MA, Khan WS, Shafique M, Khan M. Fabrication of niclosamide loaded solid lipid nanoparticles: In vitro characterization and comparative in vivo evaluation. Artificial cells, nanomedicine, and biotechnology. 2018;46(8):1926-34.
Xie Y, Yao Y. Octenylsuccinate hydroxypropyl phytoglycogen enhances the solubility and in-vitro antitumor efficacy of niclosamide. International journal of pharmaceutics. 2018;535(1-2):157-63.
Russo A, Pellosi DS, Pagliara V, Milone MR, Pucci B, Caetano W, et al. Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells. International journal of pharmaceutics. 2016;511(1):127-39.
Costabile G, d'Angelo I, Rampioni G, Bondì R, Pompili B, Ascenzioni F, et al. Toward repositioning niclosamide for antivirulence therapy of Pseudomonas aeruginosa lung infections: Development of inhalable formulations through nanosuspension technology. Mol Pharm. 2015;12(8):2604-17.
Naqvi S, Mohiyuddin S, Gopinath P. Niclosamide loaded biodegradable chitosan nanocargoes: An in vitro study for potential application in cancer therapy. Royal society open science. 2017;4(11):170611.
Zhang X, Zhang Y, Zhang T, Zhang J, Wu B. Significantly enhanced bioavailability of niclosamide through submicron lipid emulsions with or without PEG-lipid: A comparative study. Journal of microencapsulation. 2015;32(5):496-502.
Ye Y, Zhang X, Zhang T, Wang H, Wu B. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique. Drug development and industrial pharmacy. 2015;41(9):1416-24.
Kaye SS, Dailly A, Yaghi OM, Long JR. Impact of preparation and handling on the hydrogen storage properties of Zn4O(1,4-benzenedicarboxylate)3 (MOF-5). Journal of the american chemical society. 2007;129(46):14176-7.
Plum LM, Rink L, Haase H. The essential toxin: Impact of zinc on human health. International journal of environmental research and public health. 2010;7(4):1342-65.
Sheehan RJ. Terephthalic acid, dimethyl terephthalate, and isophthalic acid. In: Ullmann F, Gerhartz W, Yamamoto YS, Campbell FT, Pfefferkorn R, Rounsaville JF, editors. Ullmann's encyclopedia of industrial chemistry. 26. 7th ed: Weinheim, Germany: Wiley-VCH; 2011. p. 193-217.
Al-Jarsha H, Ghareeb M. Application of Taguchi orthogonal array in optimization of the synthesis and crystallinity of metal-organic framework-5 (MOF-5). Tropical journal of pharmaceutical research. 2023;22(12):2473-82.
Kareem RA, Naji GA-H. Natural preparation of rice husk-derived silica and eggshell-derived calcium carbonate composite as a coating material for dental implant. Journal of baghdad college of dentistry. 2022;34(1):1817-69.
Jassim ZE, Al-Kinani KK, Alwan ZS. Preparation and evaluation of pharmaceutical cocrystals for solubility enhancement of dextromethorphan HBr. International journal of drug delivery technology. 2021;11(4):1342-9.
Jassim NM, Abed ZA, Mahdi ZS. Synthesis, characteristics and study the photoluminscience of the CdSxSe1-x nanocrystaline thin film. Baghdad science journal. 2020;17(1):116-9.
Alhussainy JM, Alrubaye RT. Gas adsorption and storage at metal-organic frameworks. Journal of engineering. 2022;28(1):65-75.
Abdulrahman HA, Alias MFA. Synthesis and Characterizationof a Nano(CdO)0.94:(In2O3)0.06/ Si gas Sensor. Iraqi journal of science. 2021;22(11):3858-70.
Jithan A, Madhavi K, Madhavi M, Prabhakar K. Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int J Pharm Investig. 2011;1(2):119-25.
Al-Sarraf MA, Hussein AA, Al-Kinani KK. Formulation, characterization, and optimization of zaltoprofen nanostructured lipid carriers (NLCs). International journal of drug delivery technology. 2021;11(2):434-42.
Bhattacharyya S, Reddy P. Effect of surfactant on azithromycin dihydrate loaded stearic acid solid lipid nanoparticles. Turkish journal of pharmaceutical sciences. 2019;16(4):425-31.
Hu M, Li X. Oral bioavailability and drug delivery: From basics to advanced concepts and applications. New Jersey, USA: John Wiley & Sons, Inc.; 2024.
Luedeker D, Gossmann R, Langer K, Brunklaus G. Crystal engineering of pharmaceutical co-crystals: “NMR crystallography” of niclosamide co-crystals. Crystal growth & design. 2016;16(6):3087-100.
Jabir SA, Sulaiman HT. Preparation and characterization of lafutidine as immediate release oral strip using different type of water-soluble polymer. International journal of applied pharmaceutics. 2018;10(5):249-60.
Isaeva VI, Kustov L. Metal organic frameworks—New materials for hydrogen storage. Russian journal of general chemistry. 2007;77(4):721-39.
Lawson HD, Walton SP, Chan C. Metal–organic frameworks for drug delivery: A design perspective. ACS Applied materials & interfaces. 2021;13(6):7004-20.
Mulyati T, Ediati R, Rosyidah A. Influence of solvothermal temperatures and times on crystallinity and morphology of MOF-5. Indonesian journal of chemistry. 2015;15(2):101-7.
Al Haydar M, Abid HR, Sunderland B, Wang S. Metal organic frameworks as a drug delivery system for flurbiprofen. Drug design, development and therapy. 2017;11:2685-95.
Chen G, Luo J, Cai M, Qin L, Wang Y, Gao L, et al. Investigation of metal-organic framework-5 (MOF-5) as an antitumor drug oridonin sustained release carrier. Molecules (Basel, Switzerland). 2019;24(18):3369-86.
Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 6th edition ed. London, United Kingdom: Pharmaceutical Press; 2009.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
